Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial

Clinical trial NCT05327686 · RECRUITING

Trial details

NCT number: NCT05327686
Sponsor: NRG Oncology
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Renal Cell Carcinoma Stage III Renal Cell Cancer AJCC v8 Stage IV Renal Cell Cancer AJCC v8 Unresectable Renal Cell Carcinoma

Start date: 2023-02-01
Primary completion: 2028-06-15
Enrollment: 240

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.